The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Asia Pacific FMD vaccine market is expected to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Foot and mouth disease (FMD) refers to a transboundary animal disease that affects various animal species such as cattle, buffaloes, pigs, goats, and wild animals. They are infected by a virus that belongs to the Aphthovirus genus of the Picornaviridae family. FMD vaccine is one of the widely used control measures for the disease that can have a potentially devastating impact on the environment, society and the economy. The FMD vaccination approaches include mass vaccination applied to target animal populations, zones, and high-risk areas. At present, new inactivated FMDV DIVA markers and purified protein-based vaccines are in advanced development stages.
Asia Pacific represents the largest market for FMD vaccines, primarily driven by the increasing cattle population in the region, which accounts for more than half of the total population. The market is further propelled by the high livestock population and growing awareness regarding FMD across the region. Moreover, various countries in this region are developing a species-based vaccination strategy to control FMD outbreaks. Governments of several countries are also funding and launching initiatives and campaigns, thus leading to the bulk purchasing of FMD vaccines.
IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific FMD vaccine market report, along with forecasts for growth at the country level from 2021-2026. Our report has categorized the market based on region, animal type, vaccine type and distribution channel.
Breakup by Animal Type:
Breakup by Vaccine Type:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at